Roy Whitfield

Roy Whitfield

Director/Miembro de la Junta en NEKTAR THERAPEUTICS .

Fortuna: 1 M $ al 31/05/2026

72 años
Health Technology
Consumer Services
Commercial Services

Perfil

Roy A. Whitfield was the founder of Incyte Corp., established in 1991, where the title held was Director from 2003 to 2014.
The current job is Lead Independent Director at Nektar Therapeutics, starting in 2019 and ongoing since joining the company in 2000.
Former jobs include Executive Chairman at BioSeek, Inc.; Independent Director at Illumina, Inc. from 2011 to 2017; Director at Station X, Inc.; Director at Solexa, Inc. from 2006 to 2007; Director at Sciona, Inc.; Principal at The Boston Consulting Group, Inc.; Principal at Technicon Instruments Corp.
from 1984 to 1989; Principal at Cooper Biomedical, Inc.; and Advisor at InterWest Venture Management Co. Education includes an MBA from Stanford University and an undergraduate degree from the University of Oxford.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
06/04/2026 19.184 ( 0,06 % ) 1 M $ 31/05/2026

Cargos activos de Roy Whitfield

EmpresasCargoInicio
NEKTAR THERAPEUTICS Director/Miembro de la Junta 01/08/2000

Antiguos cargos conocidos de Roy Whitfield.

EmpresasCargoFin
ILLUMINA, INC. Director/Miembro de la Junta 30/05/2017
INCYTE CORPORATION Director Ejecutivo 01/11/2001
Director/Miembro de la Junta 25/01/2010
Corporate Officer/Principal 31/05/2008
Director/Miembro de la Junta 26/01/2007
Ver el detalle de la experiencia de Roy Whitfield.

Formación de Roy Whitfield.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

76

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Health Technology

Health Technology

Technology Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Technicon Instruments Corp.

Finance

Health Technology

-40%: ¡Descubre las mejores inversiones del futuro con las herramientas para suscriptores!
d
:
:
APROVECHAR LA PROMOCIÓN